<DOC>
	<DOCNO>NCT00907335</DOCNO>
	<brief_summary>A study determine use Retin-A Micro 0.04 % facial acne treatment patient age 9 11 safe efficacious .</brief_summary>
	<brief_title>A Study Acne Treatment Children Ages 9 11</brief_title>
	<detailed_description>Approximately 100 female male subject , age 9 11 year age , enrol randomize , double blind , multi-center study . Following satisfaction entry criterion screen procedure , subject receive either RETIN-A MICRO 0.04 % color match gel vehicle daily use 12-week treatment period . Subjects monitor safety throughout study sign symptom local irritation baseline , week 2 , 4 , 6 , 8 , 10 study completion , week 12 . Efficacy assess facial lesion count utilizing scale Investigator 's Global Evaluation Acne Severity ( IGA # 1 IGA # 2 ) Investigator 's Global Assessment Improvement ( IGA # 3 ) . All efficacy parameter exception IGA # 3 measure baseline week 2 , 4 , 6 , 8 , 10 12 . The Investigator 's Global Assessment Improvement ( IGA # 3 ) do Week 12 . At select site , photograph take Baseline week 2 , 4 , 8 12 .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>Males nonpregnant , nonnursing female , 9 11 year , facial pediatric acne vulgaris Minimum 20 noninflammatory lesion ( open close comedo ) Minimum 30 total facial lesion ( sum inflammatory noninflammatory ) Must least rating grade 3 Investigator Global Assessment Scale acne severity ( IGA # 1 ) baseline Known sensitivity ingredient study medication ; Any nodulocystic acne lesion Use acne device systemic therapy antibiotic within two month prior start throughout duration study Use systemic therapy retinoids within four month prior study start throughout duration study Topical use topical retinoids within two week prior study start throughout duration study Topical use antibiotic , steroid and/or nonretinoid topical acne product within two week prior study start throughout duration study Use experimental drug device within 60 day prior study start ; Use hormonal therapy within 3 month prior study start History evidence skin condition disease may require concurrent therapy may interfere evaluation study medication Any significant medical condition could confound interpretation study History of/or current facial skin cancer Inability refrain use facial product supply study , participate study No use tan booth , sun lamp , etc . Subject family member employee investigator</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>acne</keyword>
	<keyword>irritation</keyword>
	<keyword>objective sensory method</keyword>
</DOC>